/viestories/media/media_files/2025/01/24/5T5D2BqgyuevGFqeqQf6.png)
Morepen Laboratories Limited manufactures a whole range of pharmaceutical products in India and also exports these products out of India and the Company was founded in 1984 .
In this article, we will explore the factors affecting the Morepen Lab share price target for 2025 and beyond. We will also analyze how Morepen Lab's financial results for 2023 influence its stock value.
Table of Contents
Morepen Lab Latest News
-
Morepen Lab Share Price Today witnessed a steady downfall of 1.97%, against its previous close at Rs 50.85 per share on Wednesday.
Morepen Lab Share Price Target 2025
Explore Morepen Lab's share price target for 2025 with monthly projections. Discover the maximum and minimum price estimates, ranging from Rs 40.07 to Rs 90.80, to stay informed about its market performance and potential growth.
Month (2025) |
Maximum Target |
MinimumTarget |
January |
Rs 70.13 |
Rs 40.07 |
February |
Rs 73.21 |
Rs 42.42 |
March |
Rs 75.25 |
Rs 43.46 |
April |
Rs 78.33 |
Rs 44.44 |
May |
Rs 77.35 |
Rs 46.50 |
June |
Rs 79.40 |
Rs 46.54 |
July |
Rs 80.49 |
Rs 47.51 |
August |
Rs 82.51 |
Rs 48.68 |
September |
Rs 83.57 |
Rs 50.67 |
October |
Rs 85.65 |
Rs 51.64 |
November |
Rs 88.63 |
Rs 52.72 |
December |
Rs 90.80 |
Rs 52.78 |
Morepen Lab Share Price Target 2026 to 2030
Discover Morepen Lab's share price target for 2026 to 2030 with detailed projections. Explore maximum and minimum price estimates ranging from Rs 64.67 to Rs 205.01, and stay updated on the company's long-term growth potential.
Year |
Maximum Target |
Minimum Target |
2026 |
Rs 115.79 |
Rs 64.67 |
2027 |
Rs 140.22 |
Rs 75.23 |
2028 |
Rs 164.09 |
Rs 84.87 |
2029 |
Rs 183.99 |
Rs 93.00 |
2030 |
Rs 205.01 |
Rs 103.23 |
Morepen Lab LTD Competitors (Market Cap: 2,548 crores INR)
-
JB Chemicals & Pharmaceuticals Market Cap: 26,411.41 cr INR
-
Piramal Pharma Ltd Market Cap: 19,440.72 cr INR
-
Natco Pharma Market Cap: 17,983.30 cr INR
-
Suven Pharmaceuticals Market Cap: 15,826.30 cr INR
Points to consider before investing in Morepen Lab NSE Stock
-
Morepen Lab is a small-cap company, competing with other players in the pharmaceutical sector of India, such as JB Chemicals & Pharmaceuticals, Piramal Pharma, Natco Pharma and Suven Chemicals. Comparatively, the aforementioned companies are bigger in market capitalization but there are other bigger companies in this sector such as Sun Pharma, Cipla and Zydus Life, sitting at the top of the game. Like any other sector, the pharmaceutical industry has rough & tough competition to handle. Thus, Morepen Laboratories Limited will have to find its momentum on the stock exchange and for that, the company will be looking to improve its financial results.
-
The annual financial results of the Morepen Lab haven’t been good for the company and are a concern for investors on the exchange. MOREPENLAB FY23 annual results reflect a revenue of 14.22B and net income of 386.75M, down by -8.60% & -61.96%, respectively. This indicates a significant drop in net profit compared to the previous year’s Rs 1.02B.
-
Morepen Lab share prices have gone down over the last month period, as its financial results may have impacted the stock negatively.
Conclusion - Morepen Lab's Share
Morepen Lab's share price has had an uneven journey over the years. The stock started at Rs 94 per share in 2001 but has faced several declines since then. Currently, it is trading around Rs 50 per share, showing a drop of 47.47% since it was listed on the NSE in 2001.
FAQs
Disclaimer:
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.